These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700 [TBL] [Abstract][Full Text] [Related]
3. [Update on Kaposi's sarcoma]. Morand JJ; Lightburn E; Simon F; Patte JH Med Trop (Mars); 2007 Apr; 67(2):123-30. PubMed ID: 17691428 [TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma of the recto sigmoid colon in a patient with HIV infection and a high CD4 count. Acharya S; Ross JD Int J STD AIDS; 2007 Jul; 18(7):499-500. PubMed ID: 17623511 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of HIV-related Kaposi's sarcoma]. Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494 [TBL] [Abstract][Full Text] [Related]
6. Puzzling out new data on Kaposi's sarcoma. AIDS Alert; 1998 Jun; 13(6):suppl 1-3. PubMed ID: 11365464 [TBL] [Abstract][Full Text] [Related]
7. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma. Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836 [TBL] [Abstract][Full Text] [Related]
8. What's new in Kaposi's sarcoma research. Trethewey P STEP Perspect; 1997; 9(3):9-10. PubMed ID: 11364938 [TBL] [Abstract][Full Text] [Related]
9. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma]. Gabarre J; Bossi P Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765 [TBL] [Abstract][Full Text] [Related]
10. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection. Loke WC; Spittle MF; Mitchell S; Kulasegaram R Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908 [TBL] [Abstract][Full Text] [Related]
11. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement. Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755 [TBL] [Abstract][Full Text] [Related]
12. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus. Inoue N; Spira T; Lam L; Corchero JL; Luo W J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267 [TBL] [Abstract][Full Text] [Related]
13. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422 [TBL] [Abstract][Full Text] [Related]
14. Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension: A clinical hint about the potential role of HHV-8 in HIV-related pulmonary hypertension? Gutiérrez F; Masiá M; Padilla S; Ramos JM; Bernal E; Morales P; Pozo F; Andrada E; Martin-Hidalgo A J Clin Virol; 2006 Oct; 37(2):79-82. PubMed ID: 16884948 [TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus. Gnann JW; Pellett PE; Jaffe HW Clin Infect Dis; 2000 Apr; 30 Suppl 1():S72-6. PubMed ID: 10770915 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma. Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839 [TBL] [Abstract][Full Text] [Related]
17. Facing up to the ongoing challenge of Kaposi's sarcoma. Robey RC; Bower M Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104 [TBL] [Abstract][Full Text] [Related]
18. Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis. di Gennaro G; Canzonieri V; Schioppa O; Nasti G; Carbone A; Tirelli U Clin Infect Dis; 2001 Apr; 32(7):1100-2. PubMed ID: 11264040 [TBL] [Abstract][Full Text] [Related]
19. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. Dezube BJ Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241 [TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries. Bisacchi D; Noonan DM; Carlone S; Albini A; Pfeffer U Biol Chem; 2002 Sep; 383(9):1315-20. PubMed ID: 12437123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]